Document Detail

Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation.
MedLine Citation:
PMID:  10871738     Owner:  NLM     Status:  MEDLINE    
We report a 38-year-old patient affected by refractory adult onset Still's disease who achieved a prolonged remission following CD34-selected ABMT. The conditioning regimen was based on the use of CY and anti-thymocyte globulin. A 3.0 and 2.0 log reduction of T (CD3+) and B (CD19+) lymphocytes, respectively, was obtained using a Ceprate device to select CD34+ cells from PBSC. In the pre-transplant period (1994-1998) the patient had a chronic persistent disease course with frequent and recurrent systemic articular flares and loss of some functional abilities, despite daily prednisone, pulses of CY and immunosuppressive therapy (CYA or MTX). At the time of ABMT the patient had become non-ambulatory. Within 3 weeks of ABMT the patient showed a marked decrease in joint swelling, and morning stiffness. Joint pain and systemic symptoms disappeared, the patient was able to walk and run and gained general well being. ESR, C-reactive protein and WBC count were significantly decreased, while Hb level increased. This partial remission persisted for at least 1 year after ABMT, although at 15 months of follow-up a reappearance of moderate synovitis in the knees and wrists was noted. Our data further showed that both patient BM microenvironment and stem-progenitor cell function (as assessed by LTC-IC assay) were damaged even 1 year after CD34-selected ABMT, suggesting that the persistence of these alterations could have facilitated the favorable outcome of the disease following ABMT. Bone Marrow Transplantation (2000) 25, 1307-1310.
F Lanza; M Dominici; M Govoni; S Moretti; D Campioni; R L Corte; A Latorraca; A Tieghi; B Castagnari; F Trotta; G Castoldi
Related Documents :
17387388 - Association of hla class ii allele and haplotype frequencies with chronic myelogenous l...
7742758 - Thyroid dysfunction following bone marrow transplantation using hyperfractionated radia...
8262588 - Bone marrow transplantation for thalassemia.
20436698 - Thoracic air-leak syndromes in hematopoietic stem cell transplant recipients with graft...
17896888 - Current suicide ideation and prior suicide attempts of bipolar patients as influences o...
15515778 - Validation of the classification criteria commonly used in korea and a modified set of ...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Bone marrow transplantation     Volume:  25     ISSN:  0268-3369     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-08-21     Completed Date:  2000-08-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1307-10     Citation Subset:  IM    
Section of Hematology and BMT, University-Hospital of Ferrara, Ferrara, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hematopoietic Stem Cell Transplantation*
Remission Induction
Still's Disease, Adult-Onset / therapy*
Transplantation, Autologous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone marrow transplantation does not correct the hyper IgE syndrome.
Next Document:  Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as co...